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1009-165 Characteristics of Hypertensive Patients Associated 
With Obstructive Sleep Apnea
Dai Yumino, Koji Narui, Tetsu Yamaguchi, Shinichi Momomura, Toranomon, Tokyo, Japan
Background:
In patients with daytime hypertension (HT), Obstructive sleep apnea (OSA) is very often
associated. The relationship between OSA and daytime HT could be due to many con-
founding factors such as age, gender, obesity, and race. However, exact mechanism by
which OSA can lead to daytime HT is still unclear.
Methods and Results:
In a cross-sectional study, we examined independent factors associated with daytime HT
using multiple logistic regression analysis among a group of consecutive 506 patients
with OSA in our sleep laboratory. The diagnosis of OSA was established by polysomnog-
raphy prior to introduction of nasal continuous positive airway pressure therapy.
The patients population was aged mean 54±12yrs, and 50 females, with an apnea
hypopnea index (AHI) of 46±24 /hr. Patients were classified into 2 groups; 344(68%)
patients with daytime HT (mean 148/ 92 mmHg) and 162 without HT (mean 122/72
mmHg). In each group, we analyzed risk factors for OSA such as severity of AHI (cutoff of
20, 40 and 60), arousal index, desaturation, total sleep time, gender, body mass index
(BMI), excessive daytime sleepiness, smoking, alcohol and polynocturia. Univariate
results indicated that hypertension was significantly associated with age (per one year;
OR 1.27, P<0.001), BMI (per one; OR 1.62, P<0.001) and polynocturia (existence; OR
2.39, P<0.001). Multivariate adjustment results indicated that hypertension was signifi-
cantly associated with age (per one year; OR 1.07, P<0.001), BMI (per one; OR 1.13,
P<0.001), polynocturia (existence; OR 1.62, P=0.029).
Conclusions:
Age, BMI and polynocturia but not the severity of sleep apnea show independent factors
associated with daytime HT. This is the first study that demonstrated positive relationship
between polynocturia and daytime HT in patients with OSA. Futher investigation is
needed to elucidate the mechanism underlying between polynocturia and daytime HT
with sleep apnea.
1009-166 Pulse Pressure as Cardiovascular Risk Marker During 
Losartan or Atenolol Based Therapy in Hypertensive 
Patients With Electrocardiographic Left Ventricular 
Hypertrophy (the LIFE Trial)
Eva Gerdts, Vasilios Papademetriou, Kristian Wachtell, Markku Nieminen, Hans 
Bjornstad, Stanley Franklin, Bjorn Dahlof, Richard B. Devereux, Haukeland University 
Hospital, Bergen, Norway, Weill Medical College of Cornell University, New York, NY
Background: Pulse pressure (PP) is related to risk of cardiovascular (CV) events in
hypertension. But, less is known about modification of this risk marker by antihyperten-
sive treatment.
Methods: The influence of PP on CV events (combined CV death, stroke and myocardial
infarction) was assessed in 924 patients with ECG left ventricular (LV) hypertrophy during
4.6 years randomized treatment with losartan or atenolol within the echocardiographic
substudy in the Losartan Intervention For Endpoint reduction in hypertension study.
Results: PP was similarly reduced in both groups. A total of 89 CV events occurred dur-
ing follow up. In Cox regression analysis, in-treatment PP was inversely associated with
the incidence of CV events [HR 0.97, (CI 0.96-0.99), p=0.001] (Table 1). When evaluating
the 3 individual components of the composite CV endpoint, lower in-treatment PP was
associated with higher risk of myocardial infarction and CV death, but not independently
with stroke. When patients were grouped according to median in-treatment PP (60
mmHg), the patients with PP below median had lower LV ejection fraction and cardiac
output, and included more men, smokers and patients with a history of atrial fibrillation or
heart failure.
Conclusions: The predictive value of PP for CV events previously reported is not
observed for in-treatment PP in the present study. The finding may in part be explained
by association between lower in-treatment PP and more LV dysfunction.
Table 1. 
1009-167 How Low Is Optimal Blood Pressure With Respect to 
Hypertension Risk?
Shubha Ananthakrishnan, Ursula Guidry, Natalia V. Udaltsova, Arthur L. Klatsky, Carlos 
Iribarren, Kaiser Permanente Medical Care Program, Oakland, CA
Background: Increasing blood pressure (BP) predicts risk of cardiovascular events and
BP levels defined as hypertension (HTN). Since few studies have reported HTN risk in
relation to BP within the “optimal” range (<120/80mmHg), we studied this in a multiracial
population.
Methods: We studied 19,237 members of a prepaid health plan who, at 1978-1985
examinations, had BP < 120/80 mmHg, were free of HTN history or treatment, and
remained plan members in 1995. From 1995-2000 an out-patient HTN diagnosis was
made in 1275 subjects. Predictors of HTN were studied by logistic regression with age,
sex, body mass index, education, smoking, and marital status as covariates. Systolic and
diastolic BP (SBP & DBP) were studied separately as categorical variables with referents
of < 100 mmHg for SBP and < 70 mmHg for DBP.
Results: Adjusted relative risk (RR) of HTN diagnosis (95% confidence interval [CI]) for
SBP 100-109 mm Hg = 1.0 (0.8,1.2) and for SBP 110-119 mm Hg = 1.2 (0.99,1.4). For
DBP the RR at 70-74 mm Hg = 1.3 (1.1,1.4, p < 0.01) and at 75-79mm Hg = 1.8 (1.5,2.1,
P < 0.001). There was no relation of SBP to HTN risk in sex-race specific groups but it
was slightly stronger among younger persons: e.g., RR for 110-119 vs <100 mmHg for
persons <30 years old at baseline = 1.8 (1.1,2.9). DBP was related to HTN risk in either
sex, whites and Asian-Americans, but had the strongest relation in African-Americans:
RR for 75-79 vs < 70 mmHg = 2.5 (1.9-3.3). DBP also was more strongly related to risk in
younger persons: e.g., RR for 75-79 vs < 70 mmHg at < 30 years = 2.7 (1.9,3.9). Covari-
ates predictive of increased HTN risk included increasing age, female sex, African Amer-
ican and Asian ethnicity, body mass index, married status and cigarette smoking.
Conclusions: With respect to HTN risk these data indicate that optimal DBP is < 70
mmHg, and optimal SBP is < 100mmHg in young persons.
1009-168 Sympathetic Nerve Hyperactivity in Type 2 Diabetes: A 
Potential Cause for Increased Cardiovascular Risk
Robert J. Huggett, Eleanor M. Scott, Stephen G. Gilbey, Alan F. Mackintosh, John B. 
Stoker, David A. Mary, St James's University Hospital, Leeds, United Kingdom
Background: Sympathetic nerve activity in diabetes mellitus has only been measured in
type 1 diabetes were it has been shown to be decreased or the same as normal controls
and assumed to be due to subclinical neuropathy. Sympathetic nerve hyperactivity is
harmful to patients and has been linked to the pathogenesis of essential hypertension
and its complications. This activity has not previously been measured in type 2 diabetics
were there is a high prevalence of hypertension and cardiovascular risk. Therefore we
assessed the hypothesis that normotensive type 2 diabetic patients without neuropathy
have an increased sympathetic nerve activity.
Methods: Two groups were matched (Table) for confounding variables, which are known
to affect sympathetic activity including age, body mass index (BMI), heart rate (HR) and
mean arterial pressure (MAP). Peroneal muscle sympathetic nerve activity (MSNA) was
measured by microneurography. MSNA was obtained as the resting mean frequency of
bursts per 100 cardiac beats (b/100b). 
Results: 
There were no significant (at least P>0.05; unpaired t test), differences in age, BMI, HR 
or MAP between the two groups. MSNA however in the diabetic group was significantly 
greater (P<0.001; unpaired t test).
Conclusions: Patients with type 2 diabetes had an increase in peripheral sympathetic 
nerve activity. We speculate that this sympathetic overactivity contributes to the high 
prevalence of hypertension and increased cardiovascular risk in these patients.
1009-169 Cardiovascular Variability in Hypertensive Subjects 
With and Without Obstructive Sleep Apnea
Maria do Socorro Brasileiro Santos, Maria Ângela Casas Coelho, Sonia Togeiro, Rodrigo 
DM Plentz, Fernanda Marciano Consolim-Colombo, Maria Claudia Irigoyen, Nicola 
Montano, Eduardo Moacir Krieger, Heart Institute (InCor), University of São Paulo, 
Medical School, Brazil, São Paulo, Brazil, Federal University of São Paulo, Brazil, São 
Paulo, Brazil
Background - The strong association between obstructive sleep apnea (OSA) and sys-
temic hypertension is well recognized. One leading hypothesis is that OSA increases
sympathetic neural traffic. Spectral analysis of heart rate is a widely used noninvasive
technique for the assessment of sympathetic and vagal indexes of cardiovascular neural
control, as well as of the spontaneous baroreflex sensitivity by means of the α index. The
purpose of the present study is to investigate if systemic hypertension with OSA is
accompanied by greater changes in cardiovascular variability in relation the systemic
hypertension without OSA.
Methods and Results -Spectral analysis of RR interval and blood pressure variability
were obtained during undisturbed supine rest in 7 healthy control subjects (Controls), 7
Variable Hazard Ratio 95 % Confidence Intervals p
In-treatment PP (mmHg) 0.97 0.96-0.99 0.001
Age (years) 1.04 1.01-1.08 0.010
Female gender 0.56 0.35-0.92 0.021
Baseline PP (mmHg) 1.01 0.97-1.03 0.137
Residual LV hypertrophy 1.72 1.09-2.70 0.019
Left atrial diameter (cm) 1.39 0.94-2.04 0.100
Randomized therapy 1.01 0.67-1.54 0.951
Table showing data as mean ± SEM for the 2 groups.
Number
(Females)
Age
(Years)
BMI 
(Kg/
m2)
HR 
(Beats /
min)
MAP
(mmHg)
MSNA
(b/
100beats)
Diabetics 17(6) 54±2.5 30±1.0 70±1.7 97±1.2 67±3.3
Normals 17(8) 56±1.9 28±0.9 67±1.2 99±1.0 47±2.7
